BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14662831)

  • 1. Cutting edge: a potent adjuvant effect of ligand to receptor activator of NF-kappa B gene for inducing antigen-specific CD8+ T cell response by DNA and viral vector vaccination.
    Miyahira Y; Akiba H; Katae M; Kubota K; Kobayashi S; Takeuchi T; García-Sastre A; Fukuchi Y; Okumura K; Yagita H; Aoki T
    J Immunol; 2003 Dec; 171(12):6344-8. PubMed ID: 14662831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection.
    Miyahira Y; Takashima Y; Kobayashi S; Matsumoto Y; Takeuchi T; Ohyanagi-Hara M; Yoshida A; Ohwada A; Akiba H; Yagita H; Okumura K; Ogawa H
    Infect Immun; 2005 Nov; 73(11):7356-65. PubMed ID: 16239534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen.
    Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
    J Immunol; 2003 Oct; 171(8):4121-30. PubMed ID: 14530334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of TNF-related activation-induced cytokine-receptor activating NF-kappa B interaction in acute allograft rejection and CD40L-independent chronic allograft rejection.
    Guillonneau C; Louvet C; Renaudin K; Heslan JM; Heslan M; Tesson L; Vignes C; Guillot C; Choi Y; Turka LA; Cuturi MC; Anegon I; Josien R
    J Immunol; 2004 Feb; 172(3):1619-29. PubMed ID: 14734743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperation of TNF family members CD40 ligand, receptor activator of NF-kappa B ligand, and TNF-alpha in the activation of dendritic cells and the expansion of viral specific CD8+ T cell memory responses in HIV-1-infected and HIV-1-uninfected individuals.
    Yu Q; Gu JX; Kovacs C; Freedman J; Thomas EK; Ostrowski MA
    J Immunol; 2003 Feb; 170(4):1797-805. PubMed ID: 12574344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene.
    Fujimura AE; Kinoshita SS; Pereira-Chioccola VL; Rodrigues MM
    Infect Immun; 2001 Sep; 69(9):5477-86. PubMed ID: 11500420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen.
    Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
    J Immunol; 2003 Mar; 170(6):2912-22. PubMed ID: 12626542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of mucosal dendritic cell function by receptor activator of NF-kappa B (RANK)/RANK ligand interactions: impact on tolerance induction.
    Williamson E; Bilsborough JM; Viney JL
    J Immunol; 2002 Oct; 169(7):3606-12. PubMed ID: 12244151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity.
    Eickhoff CS; Zhang X; Vasconcelos JR; Motz RG; Sullivan NL; O'Shea K; Pozzi N; Gohara DW; Blase JR; Di Cera E; Hoft DF
    PLoS Pathog; 2016 Sep; 12(9):e1005896. PubMed ID: 27642757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy.
    Katae M; Miyahira Y; Takeda K; Matsuda H; Yagita H; Okumura K; Takeuchi T; Kamiyama T; Ohwada A; Fukuchi Y; Aoki T
    Infect Immun; 2002 Sep; 70(9):4833-40. PubMed ID: 12183527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2.
    Araújo AF; de Alencar BC; Vasconcelos JR; Hiyane MI; Marinho CR; Penido ML; Boscardin SB; Hoft DF; Gazzinelli RT; Rodrigues MM
    Infect Immun; 2005 Sep; 73(9):6017-25. PubMed ID: 16113322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine.
    Cusi MG; Del Vecchio MT; Terrosi C; Savellini GG; Di Genova G; La Placa M; Fallarino F; Moser C; Cardone C; Giorgi G; Francini G; Correale P
    J Immunol; 2005 Jun; 174(11):7210-6. PubMed ID: 15905566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
    Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM
    J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,25(OH)2 vitamin D3-stimulated osteoclast formation in spleen-osteoblast cocultures is mediated in part by enhanced IL-1 alpha and receptor activator of NF-kappa B ligand production in osteoblasts.
    Lee SK; Kalinowski J; Jastrzebski S; Lorenzo JA
    J Immunol; 2002 Sep; 169(5):2374-80. PubMed ID: 12193704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced priming of multispecific, murine CD8+ T cell responses by DNA vaccines expressing stress protein-binding polytope peptides.
    Schirmbeck R; Fissolo N; Chaplin P; Reimann J
    J Immunol; 2003 Aug; 171(3):1240-6. PubMed ID: 12874211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies.
    Kim TW; Hung CF; Boyd D; Juang J; He L; Kim JW; Hardwick JM; Wu TC
    J Immunol; 2003 Sep; 171(6):2970-6. PubMed ID: 12960321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal CD8+ T cell responses induced by an MCMV based vaccine vector confer protection against influenza challenge.
    Zheng X; Oduro JD; Boehme JD; Borkner L; Ebensen T; Heise U; Gereke M; Pils MC; Krmpotic A; Guzmán CA; Bruder D; Čičin-Šain L
    PLoS Pathog; 2019 Sep; 15(9):e1008036. PubMed ID: 31525249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination using recombinants influenza and adenoviruses encoding amastigote surface protein-2 are highly effective on protection against Trypanosoma cruzi infection.
    Barbosa RP; Filho BG; Dos Santos LI; Junior PA; Marques PE; Pereira RV; Cara DC; Bruña-Romero O; Rodrigues MM; Gazzinelli RT; Machado AV
    PLoS One; 2013; 8(4):e61795. PubMed ID: 23637908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance.
    Lubberts E; van den Bersselaar L; Oppers-Walgreen B; Schwarzenberger P; Coenen-de Roo CJ; Kolls JK; Joosten LA; van den Berg WB
    J Immunol; 2003 Mar; 170(5):2655-62. PubMed ID: 12594294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi.
    Eickhoff CS; Vasconcelos JR; Sullivan NL; Blazevic A; Bruna-Romero O; Rodrigues MM; Hoft DF
    PLoS Negl Trop Dis; 2011 Mar; 5(3):e983. PubMed ID: 21408124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.